Literature DB >> 10841506

Is cyclooxygenase-2 the alpha and the omega in cancer?

S M Prescott1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10841506      PMCID： PMC300865          DOI： 10.1172/JCI10241

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  16 in total

1.  Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.

Authors:  H Sawaoka; S Tsuji; M Tsujii; E S Gunawan; Y Sasaki; S Kawano; M Hori
Journal:  Lab Invest       Date:  1999-12       Impact factor: 5.662

2.  Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.

Authors:  M K Jones; H Wang; B M Peskar; E Levin; R M Itani; I J Sarfeh; A S Tarnawski
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

3.  Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP.

Authors:  M M Höper; N F Voelkel; T O Bates; J D Allard; M Horan; D Shepherd; R M Tuder
Journal:  Am J Respir Cell Mol Biol       Date:  1997-12       Impact factor: 6.914

4.  Host cyclooxygenase-2 modulates carcinoma growth.

Authors:  C S Williams; M Tsujii; J Reese; S K Dey; R N DuBois
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

5.  The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat.

Authors:  M Yamada; M Kawai; Y Kawai; Y Mashima
Journal:  Curr Eye Res       Date:  1999-10       Impact factor: 2.424

Review 6.  Cyclooxygenase-2 and carcinogenesis.

Authors:  S M Prescott; F A Fitzpatrick
Journal:  Biochim Biophys Acta       Date:  2000-03-27

7.  Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

Authors:  J L Masferrer; K M Leahy; A T Koki; B S Zweifel; S L Settle; B M Woerner; D A Edwards; A G Flickinger; R J Moore; K Seibert
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

8.  Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

Authors:  M Oshima; J E Dinchuk; S L Kargman; H Oshima; B Hancock; E Kwong; J M Trzaskos; J F Evans; M M Taketo
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

9.  Human cyclooxygenase-2 cDNA.

Authors:  T Hla; K Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines.

Authors:  D A Jones; D P Carlton; T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157
View more
  24 in total

Review 1.  Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.

Authors:  C Patrono; P Patrignani; L A García Rodríguez
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  Genetic and pharmacological analysis of prostanoid receptor function.

Authors:  S Narumiya; G A FitzGerald
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 3.  The COXes of Danio: from mechanistic model to experimental therapeutics.

Authors:  Stephen M Prescott; H Joseph Yost
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

4.  Specific trans-acting proteins interact with auxiliary RNA polyadenylation elements in the COX-2 3'-UTR.

Authors:  Tyra Hall-Pogar; Songchun Liang; Lisa K Hague; Carol S Lutz
Journal:  RNA       Date:  2007-05-16       Impact factor: 4.942

5.  Therapeutic targeting of dysregulated cellular communication.

Authors:  Simone Schiavone; Annalisa Contursi; Rosalia Grande; Paola Patrignani
Journal:  Ann Transl Med       Date:  2017-05

6.  Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesions.

Authors:  Mateja Legan; Bostjan Luzar; Vera Ferlan Marolt; Andrej Cor
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

7.  Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis.

Authors:  Melania Dovizio; Stefania Tacconelli; Emanuela Ricciotti; Annalisa Bruno; Thorsten Jürgen Maier; Paola Anzellotti; Luigia Di Francesco; Paola Sala; Stefano Signoroni; Lucio Bertario; Dan A Dixon; John A Lawson; Dieter Steinhilber; Garret A FitzGerald; Paola Patrignani
Journal:  J Pharmacol Exp Ther       Date:  2012-01-19       Impact factor: 4.030

Review 8.  Multiple molecular targets in cancer chemoprevention by curcumin.

Authors:  Rajesh L Thangapazham; Anuj Sharma; Radha K Maheshwari
Journal:  AAPS J       Date:  2006-07-07       Impact factor: 4.009

9.  Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells.

Authors:  Andries Zijlstra; Marco Seandel; Tatyana A Kupriyanova; Juneth J Partridge; Mark A Madsen; Elizabeth A Hahn-Dantona; James P Quigley; Elena I Deryugina
Journal:  Blood       Date:  2005-09-20       Impact factor: 22.113

10.  Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells.

Authors:  D A Dixon; N D Tolley; P H King; L B Nabors; T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.